PALATIN TECHNOLOGIES, INC. Gain (Loss) on Disposition of Other Assets
PALATIN TECHNOLOGIES, INC. (PTN) reported Gain (Loss) on Disposition of Other Assets of $3.13 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for the quarter ending 2025-06-30 was $630.00K.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for the quarter ending 2024-12-31 was $2.50M.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for the quarter ending 2024-06-30 was -$16.44K.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for fiscal 2025 was $3.13M, a 59.78% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for fiscal 2024 was $7.78M.
- PALATIN TECHNOLOGIES, INC. gain (loss) on disposition of other assets for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 3 month as first filed | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 6 month as first filed | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 9 month as first filed | Gain (Loss) on Disposition of Other Assets 12 month | Gain (Loss) on Disposition of Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $630.00K derived: sum of 2 quarters · filed 2026-05-13 | $3.13M derived: sum of 3 quarters · filed 2026-05-13 | $3.13M 10-K · filed 2025-09-23 | ||||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $2.50M derived: sum of 2 quarters · filed 2026-05-13 | $2.50M 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | $2.50M 10-Q · filed 2026-02-17 | -$2.50M 10-Q · filed 2025-02-13 | $2.50M 10-Q · filed 2026-02-17 | -$2.50M 10-Q · filed 2025-02-13 | ||||
| 2024-06-30 | -$16.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $15.61M derived: sum of 2 quarters · filed 2025-09-23 | $7.78M derived: sum of 3 quarters · filed 2025-09-23 | $7.78M 10-K · filed 2025-09-23 | -$7.78M 10-K · filed 2024-09-30 | |||
| 2024-03-31 | $15.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $7.80M derived: sum of 2 quarters · filed 2025-05-14 | $7.80M 10-Q · filed 2025-05-14 | -$7.80M 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | -$7.82M 10-Q · filed 2025-02-13 | -$7.82M 10-Q · filed 2025-02-13 | ||||||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 10-K · filed 2024-09-30 | |||||
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |